In our study, CD74 expression was found to be increased following cytokine treatment in several cancers, as well as following ICI treatment (anti-PD1, anti-PDL1, and anti-CTLA4), strongly suggesting that CD74 activates the immune response in most cancers. The gene discussed is CD74; the disease is cancer.